Metabolic dysfunction-associated fatty liver disease(MASLD)is a major public health problem that seriously affects human health.At present,some good progress has been made in the research and development of new drugs for MASLD,but there is still great space for exploration.This paper summarizes and analyzes the reasons in the current clinical status and challenges for the research and development of new drugs for MASLD.
维普
万方数据